Wedbush Forecasts Stronger Earnings for Stoke Therapeutics
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Stock analysts at Wedbush increased their Q2 2025 EPS estimates for Stoke Therapeutics in a research report issued on Tuesday, May 13th. Wedbush analyst L. Chico now expects that the company will earn ($0.51) per share for the quarter, up from their previous estimate of ($0.55). The […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Stock analysts at Wedbush increased their Q2 2025 EPS estimates for Stoke Therapeutics in a research report issued on Tuesday, May 13th. Wedbush analyst L. Chico now expects that the company will earn ($0.51) per share for the quarter, up from their previous estimate of ($0.55). The […]
